SC-13D

Company

Cell Source, Inc.

Filed

April 21, 2021

Accession Number

0001640334-21-000986

A Schedule 13D is filed when an investor acquires more than 5% of a company's shares with an intent to influence control. Learn more about SC 13D filings →